SFX by Ex Libris Inc.

Title:	Disruption of a novel gene,DIRC3, and expression ofDIRC3-HSPBAP1 fusion transcripts in a case of familial renal cell cancer and t(2;3)(q35;q21)
Source:	Genes Chromosomes & Cancer [1045-2257] Bodmer, Danille yr:2003

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kobayashi, T.. "A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice." Proceedings of the National Academy of Sciences of the United States of America 98.15: 8762-8767.
description	2.	van Slegtenhorst, M. "Identification of tuberous sclerosis gene TSC1 on chromosome 9q34." Science 277.5327 (1997): 805-.
description	3.	Noda, T. "Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice." Cancer research 59.6 (1999): 1206-11.
description	4.	Kwiatkowski, D J J. "Tsc2() mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background." Journal of Clinical Investigation 104.6 (1999): 687-95.
description	5.	Guertin, David A A. "Functional genomics identifies TOR-regulated genes that control growth and division." Current biology 16.10 (2006): 958-70.
description	6.	Juriloff, D M M. "Mouse models for neural tube closure defects." Human Molecular Genetics 9.6 (2000): 993-1000.
description	7.	Sarbassov, D.D. D. "Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB." Molecular cell 22.2 (2006): 159-168.
description	8.	Kwiatkowski, David J. "A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells." Human Molecular Genetics 11.5 (2002): 525-534.
description	9.	Hoogeveen Westerveld, M. "The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits." BMC biochemistry 13.1 (2012): 18-18.
description	10.	Pizoli, Carolyn E. "Resting-state activity in development and maintenance of normal brain function." Proceedings of the National Academy of Sciences of the United States of America 108.28 (2011): 11638-43.
description	11.	McGraw, Christopher M. "Adult Neural Function Requires MeCP2." Science 333.6039 (2011): 186-186.
description	12.	Betancur, C. "Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting." Brain research 1380.7 (2010): 42-77.
description	13.	Orlova, K. "The tuberous sclerosis complex." Annals of the New York Academy of Sciences 1184.1 (2010): 87-105.
description	14.	Copp, Andrew J J. "The genetic basis of mammalian neurulation." Nature reviews. Genetics 4.10 (2003): 784-93.
description	15.	Finnell, RH H. "Gene expression profiling within the developing neural tube." Neurochemical Research 27.10 (2002): 1165-1180.
description	16.	Kenerson, Heidi L. "Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors." Cancer research 62.20 (2002): 5645-5650.
description	17.	James, Marianne F. "NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth." Molecular and cellular biology 29.15 (2009): 4250-4261.
description	18.	Henske, Elizabeth Petri P. "Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond." Pediatric nephrology 20.7 (2005): 854-7.
description	19.	Kaess, C. "The effect of decaffeination of coffee on gastro-oesophageal reflux in patients with reflux disease." Alimentary pharmacology & therapeutics 11.3 (1997): 483-6.
description	20.	Kim, Y. "Normal insulin-dependent activation of Akt protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes." The journal of clinical investigation 104.6 (1999): 733-41.